Evidence map›Paper›PMID 17186280›Full record

ReviewPediatric nephrology (Berlin, Germany)2007

Recurrence of nephrotic syndrome/focal segmental glomerulosclerosis following renal transplantation in children.

Richard N Fine

2 registry-linked trialsOpen access · hybridAbstract readReview
In one paragraph

Review in Pediatric nephrology (Berlin, Germany), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01113385 nacompletednot on this mapstarted 2009, after this paper: background citation

Effect of Oral Galactose on the Level of Focal Sclerosis Permeability Factor and Proteinuria in Children With Steroid Resistant Nephrotic Syndrome: A Pilot Study

TypeinterventionalSponsorChildren's National Research InstituteRan2009 to 2013Enrolled7ConditionsFocal Segmental Glomerulosclerosis, Steroid Resistant Nephrotic SyndromeArmsD-Galactose
NCT02235857 narecruitingnot on this mapstarted 2015, after this paper: background citation

Treatment of Drug-resistant Pediatric Primary Focal Segmental Glomerulosclerosis Using the Liposorber® LA-15 System

TypeinterventionalSponsorKaneka Medical America LLCRan2015 to 2029Enrolled35ConditionsFocal Segmental GlomerulosclerosisArmsLIPOSORBER® LA-15 System
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 102 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Successful management of recurrent focal segmental glomerulosclerosis.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2018
    Article
  14. Article
  15. The glomerular permeability factors in idiopathic nephrotic syndrome.Pediatric nephrology (Berlin, Germany) · 2016
    Review
  16. Review
  17. Article
  18. The Impact of Histologic Variants on FSGS Outcomes.International scholarly research notices · 2014
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Richard N FineSchool of Medicine, Stony Brook University, Stony Brook, NY 11794-8111, USA. richard.fine@stonybrook.edu
Stony Brook University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of recurrence of nephrotic syndrome/focal segmental glomerulosclerosis (NS/FSGS) is variable (~30%). The incidence of recurrence is less in African-Americans than in whites and Hispanics. Graft survival rates are decreased in recipients with FSGS, especially if remission of the NS is not achieved in those with recurrence. Although controversial, the use of living donor (LD) transplants are not contraindicated; however, obligatory heterozygote parental grafts with a podocin mutation should be used with caution. Optimal treatment to induce a remission post-transplant has not been delineated. Pre-transplant and/or prophylactic post-transplant pre-operative plasmapheresis (PP) for high-risk patients--especially those with recurrence in a previous graft--may be promising. An international multicenter controlled study is required to delineate the optimal approach to prevent and/or treat the recurrence of NS/FSGS.

Indexed as

ChildGlomerulosclerosis, Focal SegmentalHumansIncidenceKidney TransplantationNephrotic SyndromeRecurrenceRisk Factors

Identifiers

PMID17186280
PMCPMC1805045
OpenAlexW1996263454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.